Follow
Bruce Kirenga
Bruce Kirenga
Chief Research Scientist and Director Makerere University Lung Institute
Verified email at chs.mak.ac.ug
Title
Cited by
Cited by
Year
Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis
BM Mayosi, M Ntsekhe, J Bosch, S Pandie, H Jung, F Gumedze, J Pogue, ...
New England Journal of Medicine 371 (12), 1121-1130, 2014
2992014
Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study
F van Gemert, B Kirenga, N Chavannes, M Kamya, S Luzige, P Musinguzi, ...
The Lancet Global Health 3 (1), e44-e51, 2015
2282015
Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis
KP Fennelly, EC Jones-López, I Ayakaka, S Kim, H Menyha, B Kirenga, ...
American journal of respiratory and critical care medicine 186 (5), 450-457, 2012
1892012
Association between household air pollution exposure and chronic obstructive pulmonary disease outcomes in 13 low-and middle-income country settings
T Siddharthan, MR Grigsby, D Goodman, M Chowdhury, A Rubinstein, ...
American journal of respiratory and critical care medicine 197 (5), 611-620, 2018
1602018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
BJ Kirenga, W Ssengooba, C Muwonge, L Nakiyingi, S Kyaligonza, ...
BMC public health 15, 1-7, 2015
1352015
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective …
SG Mfinanga, BJ Kirenga, DM Chanda, B Mutayoba, T Mthiyane, G Yimer, ...
The Lancet infectious diseases 14 (7), 563-571, 2014
1312014
Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing
TG Clark, K Mallard, F Coll, M Preston, S Assefa, D Harris, S Ogwang, ...
PloS one 8 (12), e83012, 2013
922013
Long term complications after completion of pulmonary tuberculosis treatment: a quest for a public health approach
J Chakaya, B Kirenga, H Getahun
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 3, 10-12, 2016
822016
Predictors and outcomes of mycobacteremia among HIV-infected smear-negative presumptive tuberculosis patients in Uganda
L Nakiyingi, W Ssengooba, D Nakanjako, D Armstrong, M Holshouser, ...
BMC infectious Diseases 15, 1-8, 2015
512015
Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study
BJ Kirenga, J Levin, I Ayakaka, W Worodria, N Reilly, F Mumbowa, ...
PLoS One 9 (3), e90614, 2014
502014
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2× 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone …
BM Mayosi, M Ntsekhe, J Bosch, J Pogue, F Gumedze, M Badri, H Jung, ...
American heart journal 165 (2), 109-115. e3, 2013
462013
The system can't perform the operation now. Try again later.
Articles 1–11